Evaluation the effect of azithromycin prophylaxis on decreasing the rate of post-operative infection

Evaluation the effect of azithromycin prophylaxis on decreasing the rate of post-operative infection in female candidates for elective cesarean section

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N160

Enrollment

Registered

2021-01-15

Start date

2021-01-04

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection following cesarean section. Infection following a procedure

Interventions

Intervention 1: The intervention group will receive 500 mg of oral azithromycin manufactured by Farabi company in addition to the standard protocol (cefazolin 1 g, intravenously manufactured by Farabi

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Gestational age over 37 weeks Selective cesarean section candidates No history of previous infection No sensitivity to the under study antibiotics

Exclusion criteria

Exclusion criteria: Smoker mothers Corticosteroid users Pre-pregnancy diabetes Preeclampsia Premature rupture of membranes Gestational diabetes Mothers taking azithromycin within 7 days of surgery

Design outcomes

Primary

Measure	Time frame
Wound infection rate. Timepoint: From the time of hospitalization to the time of stitches removal, the first week after surgery and 6 weeks after surgery. Method of measurement: Asking from the patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryeh Rezaei

Kermanshah University of Medical Sciences

Drmaryeh@gmail.com+98 83 3427 6306

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026